Clinical Trial Update: Alfuzosin Versus Placebo in Acute Urinary Retention [Phase 3]

View source ↗

Summary

This entry reports a terminated Phase 3 trial comparing Alfuzosin to placebo for acute urinary retention.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Retention

Drugs mentioned

• Alfuzosin (alfuzosin)

Snippet

Sponsor: Sanofi | Conditions: Urinary Retention | Phase 3 | Status: TERMINATED